600272.SHG Shanghai Kai Kai Industry Co Ltd A
- Market cap
- CNY 3.61B
- P/E
- 125.0x
- P/B
- 4.47x
- ROE
- 4.7%
- Dividend yield
- 0.30%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600272.SHG undervalued?
Graham numberThe Graham number of Shanghai Kai Kai Industry Co Ltd A cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai Kai Kai Industry Co Ltd A fundamental analysis
No fundamental analysis for Shanghai Kai Kai Industry Co Ltd A yet.
Shanghai Kai Kai Industry Co Ltd A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai Kai Kai Industry Co Ltd A
Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company is involved in the wholesale and retail of Chinese and Western medicines, prepared slices of Chinese medicinal herbs, medical devices, ginseng and tonic products, beauty and health products, and other health products and services under the Lei Yunshang brand. It also engages in the wholesale and retail of shirts, sweaters, jackets, coats, and other c…
Full company profileShanghai Kai Kai Industry Co Ltd A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai Kai Kai Industry Co Ltd A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 906M | 962M | 878M | 870M | 762M | 670M | 894M | 925M | 1.09B | 1.13B | 1.17B |
| Gross Profit | 182M | 199M | 204M | 187M | 186M | 173M | 209M | 189M | 188M | 147M | 167M |
| Operating Income | 25.8M | 49.7M | 46.6M | 33.4M | 23.5M | 25.7M | 58.1M | 55.4M | 68.9M | 30.1M | 39.7M |
| EBITDA | 47.3M | 80.1M | 72.3M | 48.0M | 38.2M | 41.8M | 82.6M | 76.5M | 88.3M | 54.9M | 56.6M |
| Net Income | 21.3M | 38.7M | 35.2M | 22.0M | 13.7M | 21.7M | 39.9M | 39.3M | 35.0M | 12.9M | 37.9M |
| EPS | 0.09 | 0.16 | 0.14 | 0.09 | 0.06 | 0.09 | 0.16 | 0.16 | 0.14 | 0.05 | 0.14 |
| Balance Sheet | |||||||||||
| Total Assets | 1.03B | 1.04B | 1.02B | 1.04B | 1.04B | 1.06B | 1.21B | 1.33B | 1.48B | 1.74B | 1.80B |
| Total Liabilities | 531M | 540M | 516M | 520M | 523M | 516M | 629M | 720M | 836M | 749M | 992M |
| Shareholders' Equity | 488M | 496M | 495M | 515M | 516M | 535M | 569M | 596M | 619M | 777M | 813M |
| Cash & Short-term Investments | 136M | 169M | 167M | 283M | 350M | 204M | 321M | 258M | 225M | 503M | 293M |
| Total Debt | - | - | - | - | 29.6M | 23.7M | 59.7M | 13.4M | 15.4M | 25.4M | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 11.3M | 72.6M | 32.1M | 20.7M | 81.7M | 26.7M | 79.3M | 578K | -61.6M | 150M | - |
| Capital Expenditure | 2.62M | 32.3M | 1.68M | 4.55M | 6.86M | 240M | 3.89M | 7.27M | 17.6M | 6.37M | 3.64M |
| Free Cash Flow | 8.65M | 40.3M | 30.4M | 16.2M | 74.8M | -214M | 75.4M | -6.70M | -79.1M | 143M | 54.4M |
| Ratios | |||||||||||
| ROE | 4.4% | 7.8% | 7.1% | 4.3% | 2.6% | 4.1% | 7.0% | 6.6% | 5.7% | 1.7% | 4.7% |
| ROA | 2.1% | 3.7% | 3.5% | 2.1% | 1.3% | 2.0% | 3.3% | 3.0% | 2.4% | 0.7% | 2.1% |
| Net Profit Margin | 2.3% | 4.0% | 4.0% | 2.5% | 1.8% | 3.2% | 4.5% | 4.2% | 3.2% | 1.1% | 3.2% |
| Debt to Equity | - | - | - | - | 0.06x | 0.04x | 0.11x | 0.02x | 0.02x | 0.03x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shanghai Kai Kai Industry Co Ltd A dividends
- Dividend yield
- 0.30%
- Forward dividend
- 0.02 CNY
- Payout ratio
- 82.6%
- Ex-dividend date
- Jul 7, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 10.7M | 0.04 | 82.6% |
| 2024 | CNY 12.2M | 0.05 | 34.9% |
| 2023 | CNY 12.9M | 0.05 | 32.9% |
| 2022 | CNY 6.56M | 0.03 | 16.4% |
| 2021 | CNY 4.13M | 0.02 | 19.0% |
| 2020 | CNY 6.79M | 0.03 | 49.7% |
| 2019 | CNY 10.9M | 0.04 | 49.8% |
| 2018 | CNY 12.3M | 0.05 | 34.8% |
| 2017 | CNY 7.20M | 0.03 | 18.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 12:10 on Apr 16, 2007.
Who owns Shanghai Kai Kai Industry Co Ltd A
- Insiders 54.09%
- Institutions 0.68%
- Public & others 45.24%
- Shares outstanding 183M
- Free float 170M
Shanghai Kai Kai Industry Co Ltd A company profile
- Company name
- Shanghai Kai Kai Industry Co Ltd A
- Ticker
- 600272.SHG
- ISIN
- CNE000001766
- Exchange
- Shanghai Stock Exchange
- Listed since
- Dec 20, 1996
- Sector
- Consumer Cyclical
- Industry
- Pharmaceuticals
- Employees
- 438
- Fiscal year end
- December
- Address
- No. 678 Changping Road, Shanghai, China, 200040
- Phone
- 86 21 6271 2002
- Website
- chinesekk.com
About Shanghai Kai Kai Industry Co Ltd A
Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company is involved in the wholesale and retail of Chinese and Western medicines, prepared slices of Chinese medicinal herbs, medical devices, ginseng and tonic products, beauty and health products, and other health products and services under the Lei Yunshang brand. It also engages in the wholesale and retail of shirts, sweaters, jackets, coats, and other clothing items under the Kai Kai brand, as well as the purchase and customization of workwear. The company was founded in 1992 and is headquartered in Shanghai, China.
Shanghai Kai Kai Industry Co Ltd A management
3- Mr. Guangliang LiuGM & Director · born 1979
- Mr. Heng ChenDeputy GM, Financial Director, Accounting Supervisor & Director · born 1974
- Ms. Yanhua ZhangBoard Secretary · born 1979